ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER
Clinical trials for ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New Two-Drug attack tested against tough lung cancer
Disease control Recruiting nowThis study is testing the safety and effectiveness of a new drug called SHR-A2102 when given with an existing immunotherapy drug (adebrelimab), with or without other cancer therapies. It aims to find the best dose and see if this combination can help control advanced or spreading…
Matched conditions: ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New hope for lung cancer patients: trial tests multiple treatment approaches
Disease control Recruiting nowThis study is testing several new drug combinations for different types of lung cancer. It will enroll 270 participants across three groups: those with newly diagnosed advanced cancer, those whose cancer has progressed after treatment, and those with cancer that can be surgically…
Matched conditions: ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Major trial tests new drug combo against standard for advanced lung cancer
Disease control Recruiting nowThis study is testing whether a new three-drug combination works better than the current standard two-drug treatment for advanced lung cancer. It involves 460 adults with newly diagnosed, advanced non-small cell lung cancer who haven't had prior treatment. The trial directly comp…
Matched conditions: ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER
Phase: PHASE3 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New hope for advanced lung cancer patients in combination therapy trial
Disease control Recruiting nowThis study is testing several new drug combinations for people with advanced or metastatic non-small cell lung cancer. Researchers want to find safe doses and see if these combinations can shrink tumors and help patients live longer. The trial will involve 152 participants and in…
Matched conditions: ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC